Package 84126-363-12

{"route": ["ORAL"], "spl_id": "3c177c34-15e6-c2d3-e063-6294a90ac8bf", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["2723022"], "spl_set_id": ["3c1773cb-f56e-c396-e063-6294a90a736b"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 CAPSULE, LIQUID FILLED in 1 BOTTLE (84126-363-12)", "package_ndc": "84126-363-12", "marketing_start_date": "20250908"}], "brand_name": "Vicks DayQuil-D COLD and SINUS plus SEVERE CONGESTION", "product_id": "84126-363_3c177c34-15e6-c2d3-e063-6294a90ac8bf", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "84126-363", "generic_name": "Acetaminophen, Guaifenesin, Pseudoephedrine HCl, Dextromethorphan HBr", "labeler_name": "The Procter & Gamble Manufacturing Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vicks DayQuil-D", "brand_name_suffix": "COLD and SINUS plus SEVERE CONGESTION", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "10 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250908", "listing_expiration_date": "20261231"}